Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of CT0594CP in Patients With Relapsed and/or Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT05893693 is registered in ClinicalTrials.gov with Aibin Liang，MD，Ph.D. as lead sponsor.

NCT NCT05893693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of CT0594CP in Patients With Relapsed and/or Refractory Multiple Myeloma or Plasma Cell Leukemia
Lead sponsor
Aibin Liang，MD，Ph.D.
Phase
Not applicable
Overall status
Unknown status
Start date
April 12, 2023
Completion date
January 1, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasma cell leukemia in relapse, relapsed and/or refractory multiple myeloma